Income Taxes (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended												12 Months Ended
	Jun. 30, 2014	Mar. 31, 2014	Dec. 31, 2013	Sep. 30, 2013	Jun. 30, 2013	Mar. 31, 2013	Dec. 31, 2012	Sep. 30, 2012	Jun. 30, 2012	Mar. 31, 2012	Dec. 31, 2011	Sep. 30, 2011	Jun. 30, 2014	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2014 Cody Laboratories, Inc.	Jun. 30, 2013 Cody Laboratories, Inc.	Apr. 10, 2007 Cody Laboratories, Inc.	Apr. 10, 2007 Cody Laboratories, Inc. Net operating loss (NOL) carry forwards with the IRS at the date of acquisition, expiring in 2026	Apr. 10, 2007 Cody Laboratories, Inc. Net operating loss (NOL) carry forwards with the IRS at the date of acquisition, expiring in 2027
Current Income Tax Expense
Federal													$ 41,497	$ 5,914	$ 1,513
State and Local													4,246	606	5
Total Current Income Tax Expense													45,743	6,520	1,518
Deferred Income Tax Expense (Benefit)
Federal													(11,613)	216	828
State and Local													(1,273)	567	254
Total Deferred Income Tax Expense (Benefit)													(12,886)	783	1,082
Total Income Tax Expense	14,019	13,280	9,800	(4,242)	1,950	1,327	1,749	2,277	812	1,057	519	212	32,857	7,303	2,600
Reconciliation of the company's federal statutory tax rate to its effective rate
Federal income tax at statutory rate (as a percent)													35.00%	34.00%	34.00%
State and local income tax, net (as a percent)													2.20%	2.60%	2.60%
Nondeductible expenses (as a percent)													0.40%	(0.20%)	5.70%
Foreign rate differential (as a percent)													0.20%	0.50%	2.00%
Income tax credits (as a percent)													(0.40%)	(2.50%)	(3.60%)
Change in tax laws (as a percent)														1.10%
Other (as a percent)													(0.90%)	(0.20%)	(1.40%)
Effective income tax rate (as a percent)													36.50%	35.30%	39.30%
Deferred tax assets:
Accrued expenses	85				61								85	61
Share-based compensation expense	1,261				1,022								1,261	1,022
Reserve for returns	3,489				2,431								3,489	2,431
Reserves for accounts receivable and inventory	8,798				2,995								8,798	2,995
Intangible impairment	5,739				6,702								5,739	6,702
Federal net operating loss	865				904								865	904
Impairment on Cody note receivable	2,018				1,964								2,018	1,964
Accumulated amortization on intangible asset	9,338				2,316								9,338	2,316
Foreign net operating loss	271				176								271	176
Other	48				80								48	80
Total deferred tax asset	31,912				18,651								31,912	18,651		2,500	2,700	3,800	1,900	1,900
Valuation allowance	(2,289)				(2,140)								(2,289)	(2,140)
Total deferred tax asset less valuation allowance	29,623				16,511								29,623	16,511
Deferred tax liabilities:
Prepaid expenses	94				66								94	66
Property, plant and equipment	3,715				3,512								3,715	3,512
Other	315				54								315	54
Total deferred tax liability	4,124				3,632								4,124	3,632
Net deferred tax asset	$ 25,499				$ 12,879								$ 25,499	$ 12,879